Pharmaceutical

Review meeting held on WHO-ICHI Framework, National Hea...

The Ministry of Ayush, Government of India, organised a high-level review meeti...

Lupin’s Ankleshwar facility receives EIR from US FDA

Global pharma major Lupin announced that it has received the Establishment Insp...

Autobahn’s elunetirom receives FDA fast track designati...

Elunetirom is an oral, once daily, brain-penetrant CNS thyroid hormone receptor ...

SK bioscience and VECOL partner on Colombia vaccine man...

This move strengthens vaccine supply resilience in Colombia and creates a pathwa...

MedTherapy details India manufacturing plans for CAR-T ...

MedTherapy, a cancer gene therapy biotechnology company with its global manufac...

Science and affordability are at the centre of our cosm...

How is Leeford Healthcare approaching opportunities in the cosmetics space, and...

Tecan establishes direct sales and specialist lab autom...

Tecan, a global provider of laboratory automation and solutions has announced t...

Pierre Fabre’s Braftovi gains CHMP positive opinion for...

The recommendation covers the use of the therapy in combination with cetuximab a...

University of Edinburgh develops cell therapy for liver...

The therapy uses patients’ immune cells, developed into mature macrophages, whic...

An emerging disruption in drug traceability for India a...

Over the past two decades, I have worked closely on serialisation and traceabil...

China+1 moment for pharma: How India can convert opport...

The global healthcare industry has long relied on China for the majority of its...

Regeneron to launch Global Capability Centre to scale o...

Regeneron Pharmaceuticals announced plans to establish the Regeneron Global Cap...

AstraZeneca, Daiichi Sankyo’s Datroway receives FDA app...

The approval allows Datroway to be used as a first-line treatment for adults wit...

Lupin receives China approval for Oseltamivir Phosphate...

Global pharma major Lupin announced that China’s National Medical Products Admi...

Navigating legal and regulatory landscape of GLP-1 drug...

India is currently facing a growing public health issue, with recent data showi...

Mr Shaunak J Dave, CEO & MD, Antares Vision Group

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...